Roflumilast CAS 162401-32-3 Assay 99.0~101.0% API
I-Ruifu Chemical Supply Roflumilast Intermediates:
Roflumilast CAS 162401-32-3
4-Amino-3,5-Dichloropyridine CAS 22889-78-7
Igama leMchiza | Roflumilast |
Izithethantonye | 3-(Cyclopropylmethoxy)-N-(3,5-Dichloropyridin-4-yl)-4-(Ddifluoromethoxy)benzamide |
Inombolo yeCAS | 162401-32-3 |
Inombolo yeCAT | RF-PI2075 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C17H14Cl2F2N2O3 |
Ubunzima beMolekyuli | 403.21 |
Ukuxinana | 1.471±0.060 g/cm3 |
Uvakalelo | Ubushushu Bubuthathaka |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystalline oMhlophe okanye ophantse wamhlophe |
Ukunyibilika | Inyibilikiswa simahla kwi-acetone, ayinyibiliki kancinci kwi-acetronitrile, ayinyibiliki kancinci kwi-anhydrous ethanol, ayinyibiliki ngokuthe ngqo emanzini. |
Indawo yokunyibilika | 157.0 ~ 162.0℃ |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | ≤0.10% |
Iintsimbi ezinzima | ≤10ppm |
I-Chloride | ≤0.01% |
Isazisi A. UV | Ubude obuphezulu bokufunxa kufuneka bube kwi-213 ~ 251nm |
Isazisi B. IR | Uluhlu lokufunxa lwe-IR lwesampulu luhambelana naleyo yereferensi enye |
Isazisi C. | Ibonisa ukusabela kweFluoride |
Izinto ezinxulumeneyo | |
Ukungacoceki Okukodwa | ≤0.10% |
Ukungcola ngokupheleleyo | <0.50% |
Izinyibilikisi ezishiyekileyo | |
Tert-Butanol | <0.10% |
Tetrahydrofuran | <0.072% |
Toluene | <0.089% |
N, N-Dimethylformamide | <0.088% |
Isivavanyi | 99.0 ~ 101.0% (Ibalwe kwisiseko esomileyo) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API;I-COPD |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Roflumilast (i-CAS: i-162401-32-3) yinto ekhethiweyo yomlomo we-phosphodiesterase-4 (PDE-4) inhibitor kunye ne-benzamide compound.Yaphuhliswa yinkampani yaseJamani iAltana ngo-1993 kwaye iyona kuphela inhibitor yomlomo ye-PDE-4 esetyenziselwa ukunyanga izifo zendlela yokuphefumla evunyiweyo ukuba ithengiswe.I-Roflumilast lichiza lokuqala lohlobo lwayo ukujolisa kwisifo semiphunga esingapheliyo esingapheliyo (COPD), kwaye ikwalichiza lokuqala lomlomo elichasene nokudumba elenzelwe izigulana zeCOPD.Iimpawu zayo ezizodwa zinokunceda ukulawula i-COPD: xa isetyenziswe ngokudibeneyo kunye ne-bronchodilators ukunyanga izigulane ze-COPD ezinzima kakhulu, i-Roflumilast ingaba nenzuzo yokunciphisa ngakumbi iimpawu kunye nezinga lokuwohloka, ngaloo ndlela iyenze ibe liyeza lokuqala elijolise kwizigulane ezine-phenotype-spAecific COPD eqhubekayo. kunye nokuphazamiseka okukhulu kokuhamba komoya okunxulumene nokukhohlela okungapheliyo kunye ne-phlegm engaphezulu.Ngaphandle kokuba lunyango lweCOPD enzima, iRoflumilast inokusetyenziselwa ukuthintela kunye nokunyanga izifo zendlela yokuphefumla yemfuyo, ukukhohlela kwe-mucosa engaphezulu kwe-bronchitis, i-asthmatic bronchitis, kunye ne-bronchitis ebukhali kunye ne-sacculitis yomoya ehamba kunye nokukhutshwa kwephecana lokuphefumla ngokungaqhelekanga.